Perrigo (NYSE:PRGO) updated its FY18 earnings guidance on Thursday. The company provided earnings per share guidance of $4.45-4.65 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $4.86. The company issued revenue guidance of ~$4.72 billion, compared to the consensus revenue estimate of $4.87 billion.Perrigo also updated its FY 2018 guidance to $4.45-4.65 EPS.
A number of research firms recently weighed in on PRGO. Argus downgraded shares of Perrigo from a buy rating to a hold rating in a research note on Monday, July 30th. Cantor Fitzgerald set a $107.00 price target on shares of Perrigo and gave the stock a buy rating in a research note on Thursday, August 9th. ValuEngine raised shares of Perrigo from a sell rating to a hold rating in a research note on Wednesday, August 8th. Wells Fargo & Co dropped their price target on shares of Perrigo from $84.00 to $77.00 and set a market perform rating for the company in a research note on Tuesday, August 21st. Finally, Canaccord Genuity set a $90.00 price target on shares of Perrigo and gave the stock a buy rating in a research note on Friday, August 17th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and four have assigned a buy rating to the stock. The stock has a consensus rating of Hold and an average price target of $87.80.
Shares of NYSE:PRGO opened at $64.07 on Friday. Perrigo has a 52 week low of $62.74 and a 52 week high of $95.93. The company has a quick ratio of 1.23, a current ratio of 1.81 and a debt-to-equity ratio of 0.52. The company has a market capitalization of $10.28 billion, a price-to-earnings ratio of 14.59, a PEG ratio of 2.43 and a beta of 0.66.
Perrigo (NYSE:PRGO) last issued its earnings results on Thursday, November 8th. The company reported $1.09 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.05 by $0.04. Perrigo had a net margin of 4.77% and a return on equity of 11.92%. The firm had revenue of $1.13 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same quarter in the prior year, the firm earned $1.39 earnings per share. The business’s quarterly revenue was down 8.0% on a year-over-year basis. On average, research analysts anticipate that Perrigo will post 4.93 EPS for the current year.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, December 18th. Stockholders of record on Friday, November 30th will be issued a $0.19 dividend. This represents a $0.76 annualized dividend and a dividend yield of 1.19%. The ex-dividend date is Thursday, November 29th. Perrigo’s dividend payout ratio (DPR) is presently 15.42%.
In related news, CEO Murray S. Kessler purchased 15,683 shares of Perrigo stock in a transaction dated Friday, November 9th. The stock was bought at an average price of $63.79 per share, for a total transaction of $1,000,418.57. Following the completion of the acquisition, the chief executive officer now directly owns 13,416 shares of the company’s stock, valued at $855,806.64. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. Also, VP Todd W. Kingma purchased 3,200 shares of Perrigo stock in a transaction dated Friday, November 9th. The stock was bought at an average price of $63.99 per share, with a total value of $204,768.00. Following the acquisition, the vice president now directly owns 23,587 shares of the company’s stock, valued at $1,509,332.13. The disclosure for this purchase can be found here. Insiders bought 29,983 shares of company stock valued at $1,950,822 in the last quarter. Corporate insiders own 6.90% of the company’s stock.
WARNING: “Perrigo (PRGO) Updates FY18 Earnings Guidance” was originally published by Transcript Daily and is the sole property of of Transcript Daily. If you are accessing this article on another website, it was illegally copied and republished in violation of US and international trademark and copyright legislation. The original version of this article can be read at https://transcriptdaily.com/2018/11/10/perrigo-prgo-updates-fy18-earnings-guidance.html.
Perrigo Company Profile
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products worldwide. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
See Also: What are retained earnings?
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.